Non-small cell Lung Cancer Personalization of First-Line Therapy

被引：0
|
作者：
Schmale, Ine
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2024年 / 47卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] First-Line Systemic Therapy for Non-Small Cell Lung Cancer
    Heist, Rebecca S.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 59 - +
  • [2] First-Line Therapy of Mutated Non-Small Cell Lung Cancer: An Update
    Stoehlmacher-Williams, Jan
    [J]. ONKOLOGIE, 2012, 35 (05): : 293 - 299
  • [3] Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer
    Yadollahi, Sina
    Harle, Amelie
    Gorf, Lauren
    Bayne, Mike
    Geldart, Thomas
    [J]. LUNG CANCER, 2022, 165 : S36 - S37
  • [4] First-line treatment for non-small cell lung cancer
    Pinn, Stephen
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2011, 72 (01) : 10 - 10
  • [5] Docetaxel as a single agent in first-line therapy of non-small cell lung cancer
    Rosell, R
    [J]. ONKOLOGIE, 2000, 23 : 16 - 17
  • [6] EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
    Fong, Thomas
    Morgensztern, Daniel
    Govindan, Ramaswamy
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (03) : 303 - 310
  • [7] Pembrolizumab for the first-line treatment of non-small cell lung cancer
    Ninomiya, Kiichiro
    Hotta, Katsuyuki
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (10) : 1015 - 1021
  • [8] Pemetrexed in first-line treatment of non-small cell lung cancer
    Esteban, Emilio
    Casillas, Marta
    Cassinello, Alejo
    [J]. CANCER TREATMENT REVIEWS, 2009, 35 (04) : 364 - 373
  • [9] Immune checkpoint inhibitors in first-line therapy of advanced non-small cell lung cancer
    Remon, Jordi
    Besse, Benjamin
    [J]. CURRENT OPINION IN ONCOLOGY, 2017, 29 (02) : 97 - 104
  • [10] Docetaxel (Taxotere®) as first-line therapy of advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    [J]. ONKOLOGIE, 2003, 26 : 26 - 32
12345